AIG1
Androgen-induced gene 1 protein
Also known as: AIG-1, AIG1_HUMAN, dJ95L4.1, FLJ10485
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NVV5
- Gene
- AIG1
- Ensembl
- ENSG00000146416
- Chromosome
- 6
- Canonical length
- 238 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Enables hydrolase activity. Involved in long-chain fatty acid catabolic process. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
238 residues, UniProt reviewed canonical sequence.
>Q9NVV5|AIG1
1 MALVPCQVLR MAILLSYCSI LCNYKAIEMP SHQTYGGSWK FLTFIDLVIQ AVFFGICVLT
61 DLSSLLTRGS GNQEQERQLK KLISLRDWML AVLAFPVGVF VVAVFWIIYA YDREMIYPKL
121 LDNFIPGWLN HGMHTTVLPF ILIEMRTSHH QYPSRSSGLT AICTFSVGYI LWVCWVHHVT
181 GMWVYPFLEH IGPGARIIFF GSTTILMNFL YLLGEVLNNY IWDTQKSMEE EKEKPKLELocalizationUniProt · AlphaFold · HPA
Whether an antibody against AIG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 220 nTPM
Expression across tissuesHPA
Tissue
- liver: 220 nTPM
- kidney: 95 nTPM
- choroid plexus: 53 nTPM
- spinal cord: 51 nTPM
- duodenum: 44 nTPM
- small intestine: 43 nTPM
Single-cell type
- esophageal apical cells: 527 nCPM
- proximal tubule cells: 420 nCPM
- hepatocytes: 418 nCPM
- enterocytes: 354 nCPM
- myonuclei: 324 nCPM
- cardiomyocytes: 301 nCPM
Immune cell
- non-classical monocyte: 36 nTPM
- myeloid DC: 33 nTPM
- intermediate monocyte: 30 nTPM
- MAIT T-cell: 15 nTPM
- naive CD4 T-cell: 13 nTPM
- memory CD4 T-cell: 13 nTPM
Brain region
- white matter: 79 nTPM
- hypothalamus: 77 nTPM
- spinal cord: 72 nTPM
- pons: 70 nTPM
- thalamus: 67 nTPM
- medulla oblongata: 66 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.38
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AIG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AIG1 as an antibody target. Whether an autoantibody or antibody against AIG1 could matter depends on whether native AIG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AIG1 is annotated at the cell surface, where native AIG1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AIG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...